Murine monoclonal antibody to platelet factor 4/heparin complexes as a potential reference standard for platelet activation assays in heparin-induced thrombocytopenia

Clinical and Applied Thrombosis/Hemostasis

Volumn 19, Issue 1, 2013, Pages 37-41

  Asada, Reiko ^a   Wanaka, Keiko ^b,c   Walenga, Jeanine ^d   Prechel, Margaret ^d   Miyashita, Kumiko ^b   Escalante, Vicki ^d   Kaneko, Chieko ^b   Hoshino, Nobuhiro ^e   Oosawa, Mitsuru ^e   Matsuo, Miyako ^a  

^a HYOGO CANCER CENTER   (Japan)

^b Kobe Research Projects on Thrombosis and Haemostasis   (Japan)

^c KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^e LSI MEDIENCE CORPORATION   (Japan)

Author keywords

anti PF4 heparin complex antibody; heparin induced thrombocytopenia; murine monoclonal antibody; platelet activation assay; quality control

Indexed keywords

CAPREOMYCIN; FC RECEPTOR IIA; HEPARIN; HEPARIN PLATELET FACTOR 4 ANTIBODY; MONOCLONAL ANTIBODY; RECOMBINANT THROMBOCYTE FACTOR 4; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; FEMALE; GROWTH INHIBITION; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; HUMAN CELL; IMMUNE FUNCTION TEST; IMMUNOREACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEROTONIN RELEASE ASSAY; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION TEST;

ANIMALS; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTICOAGULANTS; FEMALE; HEPARIN; HUMANS; MICE; MICE, INBRED BALB C; PLATELET AGGREGATION; PLATELET FACTOR 4; PLATELET FUNCTION TESTS; REFERENCE STANDARDS; THROMBOCYTOPENIA;

EID: 84871597151     PISSN: 10760296     EISSN: 19382723     Source Type: Journal    
DOI: 10.1177/1076029612453763     Document Type: Article

References (22)

1. Chong BH, Berndt MC. Heparin-induced thrombocytopenia. Blut. 1989 ; 58 (2). 53-57
2. Amiral J, Bridey F, Dreyfus M, et al. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost. 1992 ; 68 (1). 95-96
3. Kelton JG, Sheridan D, Santos A, et al. Heparin-induced thrombocytopenia: laboratory studies. Blood. 1988 ; 72 (3). 925-930
4. Warkentin TE, Hayward CP, Boshkov LK, et al. Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia. Blood. 1994 ; 84 (11). 3691-3699
5. Blank M, Shoenfeld Y, Tavor S, et al. Anti-platelet factor 4/heparin antibodies from patients with heparin-induced thrombocytopenia provoke direct activation of microvascular endothelial cells. Int Immunol. 2002 ; 14 (2). 121-129
6. Pouplard C, Iochmann S, Renard B, et al. Induction of monocyte tissue factor expression by antibodies to heparin-platelet factor 4 complexes developed in heparin-induced thrombocytopenia. Blood. 2001 ; 97 (10). 3300-3302
7. Arepally GM, Mayer IM. Antibodies from patients with heparin-induced thrombocytopenia stimulate monocytic cells to express tissue factor and secrete interleukin-8. Blood. 2001 ; 98 (4). 1252-1254
8. Otis SA, Zehnder JL. Heparin-induced thrombcytopenia: current status and diagnostic challenges. Aml J Hematol. 2010 ; 85 (9). 700-706
9. Bidet A, Tardy-Poncet B, Desprez D, et al. Clinical characteristics and laboratory testing of patients with suspected HIT: a survey on current practice in 11 university hospitals in France. Thromb Res. 2010 ; 125 (6). e294 - e299
10. Prechel MM, Walenga JM.. The Laboratory diagnosis and clinical management of patients with heparin-induced thrombocytopenia: an update. Semin Thromb Hemost. 2008 ; 34 (1). 86-96
11. Sheridan D, Carter C, Kelton JG. A diagnostic test for heparin-induced thrombocytopenia. Blood. 1986 ; 67 (1). 27-30
12. Chong BH, Burgess J, Ismail F. The clinical usefulness of the platelet aggregation test for the diagnosis of heparin-induced thrombocytopenia. Thromb Haemost. 1993 ; 69 (4). 344-350
13. Price EA, Hayward CP, Moffat KA, et al. Laboratory testing for heparin-induced thrombocytopenia is inconsistent in North America: a survey of North American specialized coagulation laboratories. Thromb Haemost. 2007 ; 98 (6). 1357-1361
14. Köhler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975 ; 256 (5517). 495-497
15. de StGroth SF, Scheidegger D. Production of monoclonal antibodies: strategy and tactics. J Immunol Methods. 1980 ; 35 (1-2). 1-21
16. Prechel MM, Jeske WP, Walenga JM. Physiological changes in membrane-expressed platelet factor 4: implications in heparin-induced thrombocytopenia. Thromb Res. 2010 ; 125 (4). e143 - e148
17. Warkentin TE, Greinacher A Heparin-Induced Thrombocytopenia. 4 th ed. New York, NY: Informa; 2007:227-260. TE Warkentin A Greinacher, ed. New York, NY: Informa ; 2007: 227-260.
18. Warkentin TE. Platelet count monitoring and laboratory testing for heparin-induced thrombocytopenia. Arch Path Lab Med. 2002 ; 126 (11). 1415-1423
19. Arepally GM, Kamei S, Park KS, et al. Characterization of a murine monoclonal antibody that mimics heparin-induced thrombocytopenia antibodies. Blood. 2000 ; 95 (5). 1533-1540
20. Gerotziafas GT, Elalamy I, Lecrubier C, et al. The role of platelet factor 4 in platelet aggregation induced by the antibodies implicated in heparin-induced thrombocytopenia. Blood Coagul Fibrinolysis. 2001 ; 12 (7). 511-520
21. De Reys S, Blom C, Lepoudre B, et al. Human platelet aggregation by murine monoclonal antiplatelet antibodies in subtype-dependent. Blood. 1993 ; 81 (7). 1792-1800
22. Warkentin TE, Hayward CP, Smith CA, Kelly PM, Kelton JG. Determinants of donor platelet variability when testing for heparin-induced thrombocytopenia. J Lab Clin Med. 1992 ; 120 (3). 371-379